Replies to post #102199 on Biotech Values

[DewDiligence]

Thanks, Regulardoc—that’s helpful info. To your knowledge, do any docs and patients “cheat” by using the 80mg graduated syringe for 40mg BID dosing even though the syringes are intended for single use only?

[urche]

Thanks, Regulardoc, for your estimates of various enoxaparin doses. As another hospital based internist, I think your figures seem right on.
I'll make a prediction that we will be seeing a modest increase in utilization of enoxaparin driven by lower cost. The reason is increasing evidence that the risk of developing DVT doesn't end when a patient is discharged. Out of sight, but not out of risk. Orthopedic patients often get prophylaxis for 3 wks after surgery in the area I work. But, medical patients , based on the evidence , especially the frail and semi-ambulatory, should probably also be getting anticoagulation for up to a month after acute illness. So, to the extent that lower price will drive utilization in that underserved niche, I think there is reason to think we will see increased utilization of the 30 and 40 mg daily dosage.

Urche (in Vt/NH)